Patient-based cost-effectiveness analysis of FOLFIRI versus FOLFOX7 for advanced gastric adenocarcinoma in China: A 4-year prospective randomised phase II study.
Eur J Cancer Care (Engl)
; 29(1): e13196, 2020 Jan.
Article
in En
| MEDLINE
| ID: mdl-31825141
Full text:
1
Database:
MEDLINE
Main subject:
Stomach Neoplasms
/
Camptothecin
/
Adenocarcinoma
/
Antineoplastic Combined Chemotherapy Protocols
Type of study:
Clinical_trials
/
Health_economic_evaluation
/
Prognostic_studies
/
Risk_factors_studies
Country/Region as subject:
Asia
Language:
En
Journal:
Eur J Cancer Care (Engl)
Year:
2020
Type:
Article
Affiliation country:
China